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Cells that express all five proteins of vesicular stomatitis virus 
from cloned cDNAs support replication, assembly, and budding 
of defective interfering particles 
(ncdnia virlL'l.T7 RNA polymerase/coexpression / hdptr-indeptndent budding) 
As IT K. PATTNA tK AND GAIL W. WERTZ· 
Do:partment of Microbi0!08y. The University of Alabama at Binningham Medical School. Binningham. AL 3~294 
CommllniC(JIed by Ed",in D. Kilbat/me . No~emher 26. /990 
ABSTRACT An alternative approach to structure-
function analysis of vesicular stomatitis virus (VSV) gene 
products and their interactions with one another during each 
phase of Ihe viral life cycle is described. We showed previously 
by using the vaccinia virus·T7 RNA polymerase expression 
system that when cells expressing the nucleocapsid protein (N), 
Ihe phosphoprotein (NS), and the large polymerase protein (L) 
of VSV were superinfeaed with defective interCering (01) 
particles, rapid and efficient replication and amplification of 01 
particle RNA occurred. Here, we demonstrate that all five VSV 
proteins can be expressed simultaneously when cells are co· 
transfected with plasmids containing Ihe matrix protein (M) 
gene and Ihe glycoprotein (G) gene of VSV in addition 10 
plasmids containing the genes for the N, NS, and L proteins. 
When cells coexpressing all five VSV proteins were superin-
feded with 01 particles, which because of their defectiveness 
are unable to express any viral proteins or to replicate, DI 
particle replication, assembly, and budding were observed and 
inCectious DI particles were released into the culture nuids. 
Omission of either the 1\-1 or G protein expression resnlted in no 
01 particle budding. The vector.supported 01 particles were 
similar in size and morphology to the authentic DI particles 
generated from cells coinfected with 01 particles and helper 
VSV and their infectivity could be blocked by anti·VSV or 
anti·G antiserum. The successful replication, assembly, and 
budding of 01 particles from rells expressing all live VSV 
proteins from cloned cDNAs provide a powerful approach for 
detailed structure-Cunctlon analysis of the VSV gene products 
in each step of the replicative cycle of the virus. 
A detailed analysis of the structure and fu nction of negative· 
strand RNA virus proteins and their interactions with one 
another in the replicative cycle has suffered from the lack of 
a method for genetic manipulation. Introduction of site· 
directed alterations in genomes of negative·stranded RNA 
viruses has been limited because the naked genomic RNA is 
not biologically active or infectious. The functional template 
for transcription and replication is the nucleocapsid structure 
that contains the genomic RNA encapsidated with nucleo· 
capsid protein. Several different approaches are now avail· 
able to generate viral genomic RNAs from cDNA clones in 
vitro. However, for negative·strand viruses, these genomic 
RNAs must be assembled into nucleocapsid structures to 
obtain biological act ivity. The difficulty in generating biolog-
ically ac tive nucleocapsids of negative·strand RNA viruses 
has provided a major stumbling block for detailed genetic 
analysis of this group of viruses. Only recently, synthetic 
transcripts representing the genomic RNAs of two negative· 
strand RN A viruses. measles and influenza, have been as-
sembled into biologically active nucleocapsids (1-3). These 
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accomplishments hold great promise as experimental sys-
tems for genetic manipulation of negative·strand virus ge-
nomes. In both cases, however, the success of the system 
was closely tied to the biology of the virus. Therefore, 
alternative approaches to study structure-function analysis 
of viral proteins would be useful. 
Vesicular stomatitis virus (VSV), a rhabdovirus, contains 
fi ve structural proteins and each of these proteins plays a role 
in replication, assembly. and budding ofVSY . The genomic 
RNA of VSV is a single-stranded 1l ,161-nucleotide-long 
RNA (4, 5) of negative polarity, which is encapsidated with 
the nucleocapsid protein (N) as a nucleocapsid structure. The 
active template for transcription and replication is the nucle-
ocapsid structure that contains two other minor proteins, the 
phosphoprotein (NS) and the large polymerase protein (l ), 
both of which are required for the RN A polymerase activity 
ofVSV (6-8) . These three proteins-namely, the N, NS, and 
l proteins-are the only proteins that are required for 
transcription and replication of VSV (8). The ectodomain of 
the glycoprotein (G) 'of VSV forms the spikes on the viral 
envelope and interacts with virus receptors on susceptible 
cells (9). There is evidence that the cytoplasmic domain of the 
G protein is required for assembly of VSV (10, 11). Several 
lines of evidence indicate that the matrix protein (M) plays a 
crucial role in the assembly and budding processes of VSY. 
The M protein assembles at the inner surface of the plasma 
membrane and is thought to interact with the G protein and 
the viral nucleocapsid structures (12-15). The M protein is 
also involved in the condensation of nucleocapsids into the 
tightly coiled structures that are found in mature virions (16, 
17). 
In this communication, we describe an alternative ap-
proach to the study of YSV proteins and their interactions 
with each other during replication, assembly, and budd ing of 
VSV . We have previously shown that transfection of plasmid 
DNAs containing VSV genes under the control ofa 17 RNA 
polymerase promoter into cells infected with a recombinant 
vaccinia virus that contains and expresses the gene for 
bacteriophage 17 RNA polymerase results in high-level 
expression of the VSV proteins (8). Coexpression of the N, 
NS, and L proteins of YSV in cells allows rep lication and 
amplification of defective interfering (OJ) particle RNA of 
VSV (8) . We and others have also shown that the G and M 
proteins can be expressed in fu nctional forms by using the 
same expression system (11 , 18-20). We demonstrate here 
that by transfecting plasmids containing cDNA clones for all 
fi ve of the VSY genes into cells. it is possible to express all 
five VSV proteins such that they can support repl ication, 
Abbreviations: VSV. vesicular stomatitis virus: DI. defective inter-
fering; N protein. nucleocapsid protein; NS protein . phosphoprotein; 
L protein, large polymel"ll.se protein; M protein. matri~ protein; G 
protein, glycoprotein. 
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assembly. and budding of infectious DI particles from these 
cells. This system will allow us 10 study detailed struclUre-
function aspects of each of the viral proteins and the role of 
these proteins in each step of the viral replicative cycle. 
MATERIALS AND METHODS 
Cell Cultures and Viruses. Baby hamster kidney cells 
(BHK-2l) were maintained as monolayer cultures in minimal 
essential medium (MEM ) containing 5% heal·inactivated 
felal bovine serum and 5% newborn calf serum. VSV (lndi· 
ana serOlype. San Juan strain) was propagated in BHK-21 
cells. Stocks of DI-T particles (21) were prepared as de-
scribed (8), Recombinant vaccinia virus (vTF7-) containing 
the T1 RNA polymerase gene has been described (22) and 
was kindly provided by Bernard Moss (National Institutes of 
Health , Bethesda, MD). StocksofvTF1-3 were prepared and 
infectivity titers were determined as described (8). 
PllISmid Vectors and cDNA Clones . The plasmids pAP·N. 
pMB-NS , and pAP-L contai ning the N gene, the NS gene, 
and the L gene , respectively , have been described (8). The 
plasmid pKOM2 containing the wild·type M gene (Indiana 
serotype) inserted into the pGEM4XB vector has been de-
scribed (23) and was kindly provided by Manfred Schubert 
(Nalionallnsti tutes of Health). This plasmid contains the M 
gene under the control ofTI RN A polymerase promoter. The 
plasmid pTF·G contains the VSV G gene (Indiana serotype) 
under the conlrol of the TI RNA polymerase promoter and 
transcriptional terminator in pTF1-5 (24). This plasmid was 
kindly provided by M. Abdul Jabbar (UniveN;ity of Califor-
nia-Los Angeles , Los Angeles). Plasmids were prepared and 
purified as described (25). 
Virus Infection, DNA Transfection, and Radioactil'e Label· 
ing. BHK-21 cells in 6()..mm plates were infected with the 
recombinant vaccinia virus vTF1·3 and transfected with 
plasmid DNA using the calcium phosphate precipitation 
method as described (8 . 26). Radioactive labeling of proteins 
with [l'Slmethionine (20~Ci/ml : I Ci = 37 G8q)and of RNA 
with IlH]uridine (20 ~Ci/ml) was also performed as detailed 
(8). 
Immunoprecipitalion and Electrophoretic Analysis or Pr0-
teins. Cytoplasmic extracts of cells were prepared and virus· 
specific proteins were immunoprecipilaled as described (8) 
by using either a mouse pol yclonal antiserum raised against 
purified VSV or a monospecific rabbit antibody raised against 
an amino-terminal peptide from the L protein (27) kindly 
supplied by Manfred Schubert or both. Proteins were ana-
lyzed by electrophoresis in 10% polyacrylamide gels by using 
the buffer system of Laemmli (28) and detected by fluorog-
raphy (29). 
Analysis of DI Particle RNA Replication . Replication of 01 
particle RNA was analyzed by immunoprecipitation of nu-
cleocapsids as described (8). IJHIUridine·labeled RNAs re-
covered from immunoprecipitated nucleocapsids were re-
solved by electrophoresis in 1.75% agarose/ citrate/ urea gels 
(30) and detected by flu orography (31). 
Electron Microscopy. 01 particles generated from cell s 
coinfected with helper VSV and 01 particles or from cells 
expressing all fi ve VSV proteins were analyzed by transmi s· 
sion electron microscopy. Clarified culture fluids were pel-
leted through a cushion of 5% sucrose in 10 mM Tris·HCI . pH 
7.4/100 mM NaCI/l mM EOTA (NTE). The pellets were 
resuspended in NTE, and aliquots of each sample were 
negatively stained with uranyl acelate and visualized by using 
a Phillips 301 transmission electron microscope. 
Antibodies. Anti·VSV antibodies were raised in mice 
against gradient-purified VSV. The monoclonal antibody 
(DC3) to the G protein was kindly provided by Richard 
Compans (U niversity of Alabama at Birmingham). The 
monoclonal antibodies (1004. 22F9. 19810. and 8CllFIO) to 
Proc. NtJ ti. Acad. Sci. USA 88 (1991) 
the VSV N protein were a generous gift rrom D. Lyles (Wake 
Forest University. Winston·Salem . NC). 
RESULTS 
Expression of Viral Proteins in Transrected Cells. We have 
previously shown (8) that the N protein. the NS protein , and 
the L protein of VSV can be coexpressed in HEp·2 cells by 
cotransfection of plasmids containing the individual VSV 
genes using the recombinant vaccinia virus-TI RNA pol y-
merase expression system (22). The N, NS. and L proteins 
expressed in this manner were shown to support replication 
orDl particle RNA (8). Here we determined whether all five 
VSV protei ns could becoexpressed in cells by cotransfection 
of plasmids containing the genes for each or the five VSV 
proteins. BHK·21 cell s cotransfected with plasmids contain· 
ing the individual VSV genes were labeled with IlsS]methio-
nine. Total cytoplasmic proteins or immunoprecipitated pro· 
teins from cytoplasmic extracts were analyzed by SOS/ 
PAGE. All fi ve VSV proteins were coexpressed in cultures 
cotransfected with all five plasmids (Fig. 1. lanes 4 and 7). 
The molar rat ios or the G. N, and M proteins expressed in 
cotransfected cells and that of the proteins present in VSV-
infected cells were comparable (lanes 7 and 8). Significant 
levels of the Land NS proteins were expressed in cotrans-
fected cells (lanes 3. 4. 6. and 7). However. the amounts of 
the Land NS proteins relative to other VSV proteins in cells 
cotransfected with all fi ve pJasmids were less than that in 
VSv ·infected cells (compare lanes 4, 7. and 8) or that in cells 
expressing only the N. NS. and L proteins (lanes 3 and 6). 
Further experiments have demonstrated that the expression 
of the M protein depresses the level of eXpression of other 
VSV proteins when coexpressed (unpublished results). 
Assembly and Budding of DI Particles (rom Cells Expressing 
All Five VSV Proteins. The ability or the five VSV proteins 
coexpressed in cells by transfection or plasmids containi ng 







FIG. L Coexpression of V5V proteins in cOiransfecled cells. 
CeUs infected with vTFI·) and transfeCled with no plasmid (lanes 2 
and S). S ~g of pAP·L. 10 ~g of pMB·NS, and IS "g of pAP_N (lanes 
) and 6). or S " g of pAP·L. 10 ~g of pMB·NS, IS "g of pAP·N. 10 
'" of pKOM2 . and 15 "g of pTF·G (lanes 4 and 7) were labeled with 
t)!lSjmelhionine. Total cytoplasmic proteins (lanes 2-4) or proteins 
immunopredpitated from cytoplasmic exlracts with anti· VSV anti-
bodies (lanes S-7) were analyzed by SOS/PAGE . Proteins from 
mock·infected (lane I) and VSV·infecled (lane 8) cells are also 
shown. 
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replication, assembly, and budding was examined, The DI 
particles cannot replicate on their own because they do not 
contain the genetic information to code for any functional 
VSV proteins, Normally, coi nfection with helper virus is 
required to provide the functional viral proteins for replica-
tion, assembly, and budding of the 01 particles, The protocol 
to analyze assembly and budding of DI particles from cells 
expressing viral proteins is as follows. Cells infected with 
vTF7·3 were transfected with various combinations of plas-
mid ONAs containing the individual genes for the VSV 
proteins. At 5 hr after transfection. the cells were superin-
fecled wilh 01 particles. After vi rus adsorption, the cells 
were washed twice in warm MEM and then incubated al370C 
with I ml of MEM. Culture fluids from these cells (passage 
1) were collected at 20-24 hr after OJ particle superinfection 
and clarified by centrifugation at 16.000 x g for 1 min at4QC. 
Half (500 ~I) of the clarified culture fluids was used to infect 
(as in passage 1) a second set of cells (passage 2) that had been 
infected with vTF7-3 and transfected with the same combi· 
nation of plasmid DN As as in the first passage. Culture fluids 
from passage 2 were collected at 20-24 hr after infection and 
clarified as above. It was necessary to carry out two passages 
to avoid the possible carry-over of any OJ particles used in 
the primary infection that may have been present in passage 
I culture fluids due to the release of adsorbed DI particles that 
did not penetrate the cells. The presence of infectious 01 
particles in the culture fluids from passage 2 cells was assayed 
by the RNA replication assay (8) in cells expressing the N. 
NS, and L proteins of VSV. After two passages, OJ particles 
were not detected in the culture fluids of cells that did not 
express any viral proteins (Fig. 2, lane 2) or cells that 
expressed only the N, NS, and L proteins (lane 3). Expres-
sion of the N, NS, and L proteins in combination with either 
the M or G proteins also did not support viral budding (Fig. 
2, lanes 4 and 5, respectively) . OJ panicles were detected, 
however. in the culture fluids of cells that expressed the M 
and G proteins in addition to the N, NS , and L proteins (lane 
6). These results show that DI particle budding occurred only 
when all five VSV proteins were coexpressed and that the M 
and G proteins are required for assembly and budding of 
infectious OJ panicles. 
To demonstrate that the vector-supported budded 01 par· 
ticles were mature particles containing the viral G protein in 
the envelope with the nucleocapsids enclosed inside, we tested 
antibodies against the G or N protein or against all five VSV 
proteins for their ability to block the infectivity of the vector-
supported budded panicles present in the culture fluids. 
Purified authentic 01 panicles or the budded panicles from 
culture fluids of cells expressing all five VSV proteins were 
treated separately with antibodies raised against VSV, a 
monoclonal antibody to the G protein, or a combination offour 
monoclonal antibodies to the N protein. The monoclonal 
antibody to the G protein neutralizes the infectivity of VSV 
(unpublished result). The monoclonal antibodies to the N 
protein are known to bind nucleocapsids (J. Glass and 
G.W.W., unpublished observation) and previous work has 
shown that such anti-N monoclonal antibodies block the 
transcription and replication capabilities of nucleocapsids (32). 
The ability of antibody-treated OJ particles and vector-
supported budded particles in the culture fluids to direct 
replication of their genomic RNA was examined in cells that 
were infected with helper VSV. The results in Fig. 3 show that 
anti-VSV and anti-G antibodies inhibited the genomic RNA 
replication of authentic OJ particles used as a control (lanes 2 
and 3) as well as Ihat of the DI particles budded into the culture 
fluids of cells expressing all five VSV proteins (lanes 6 and 7). 
However, the anti·N antibodies (lanes 4 and 8) had no effe<:t 
on infectivity, and RNA replication directed by both types of 
01 particles was observed at levels similar to those obtained 
in the absence of the antibodies (lanes 1 and 5). Taken 
Prm:. Nail. Acad. Sci. USA 88 (/991} 1381 
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FIG. 2. ,Assay for the presence of 01 panicles in the culture 
fluids . Passage 2 culture fluids from cells transfected with no plasmid 
(lane 2). 15 ",g ofpAP·N, 10 pog of pMB·NS. and 5 JLg ofpAP·L (1ane 
3). 15 ",g of pAP-N. 10 pog of pMB·NS, 5 JLg of pAP·L. and 10 ",g of 
pKOM2 (lane 4). 15 pog of pAP-N, 10 pog of pMB·NS, 5 ~g of pAP-L. 
and 10 ",g ofpTF·G (lane S), or IS ",g ofpAP·N. 10 ~g of pMB-NS. 
5 pog of pAP·L, 10 ",g of pKOM2, and 10 ~g of pTF.G (lane 6) were 
analyzed for 01 panicles using an RNA replication assay. The RNA 
replication assay was performed by labeling with [JHluridine in cells 
that were transfected with 15 ",gofpAP·N, 10 ",8 ofpMB·NS, and 
5 ",g of pAP·L plasmid DNA. Labeled RNAs present in immuno· 
precipitated nucleocapsids from the cytoplasmic extracts were an· 
alyzed in an agarose/urea gel. Lane 1 shows 01 RNA replication 
supported by the same system using 500 ",I of 1 :500 dilution of 
authentic purified 01 stock virus. 
together. these results indicate that the particles that are 
present in the culture fluids of cells expressing all five VSV 
proteins contained G protein on the surface of the envelope 
and that the nucleocapsid structures were enclosed within the 
envelope in a manner similar to that of the authentic OJ 
particles generated from cells coinfected with helper VSV. 
The presence of budded OJ particles in culture fluids was 
also examined by electron microscopy. The culture fluids of 
cells coinfected with helper VSV and Dl particles contained 
a large number of DI particles in addition to some VSV 
particles (Fig. 4A). These Dl particles were approximately 
one·third of the size of the typical bullet-shaped wild·type 
VSV particles and appeared to be spherical. Particles similar 
in size and morphology to the authentic 01 particles were also 
seen in the culture fluids of cells eXpressing all five VSV 
proteins (arrows in Fig. 48). Culture fluids of vTF7-3-infected 
cells expressing only the N, NS, and L proteins did not 
contain any particles similar to authentic OJ particles (data 
not shown). The number of particles generated from cells 
expressing all five VSV proteins amounted to 5-10% of the 
OJ particles generated from helper VSV-coinfected cells. 
DISCUSSION 
In this report, we demonstrate that cells eXpressing all five 
structural proteins of VSV from cloned cON As, when in· 
fected with OJ particles. allow replication, assembly, and 
1382 Biochemistry: Pannaik and Wertz 







FIG.). Infectivity of 01 particles in the presence of various 
antibodies. Purified 01 stock virus or 01 particles present in passage 
2 culture fluids from cells transfected with amounts of plasmid ONA 
as described in Fig. 2. lane 6. were treated with no antibodies (lanes 
1 and S), anti-VSV antibody (l:2S dilution; lanes 2 and 6), monoclonal 
antibody DC), to the G protein (1:2S dilution; lanes) and 7), or a 
combination offour monoclonal antibodies to N protein (l:.50dilution 
of each: lanes 4 and 8) for 2 hr at 4"C. The D1 stock virus or culture 
fluids were then used in the RNA replication assay in cells infe<:ted 
with helper VSV as described (8). 
budding of infectious 01 particles. Expression of all five VSV 
proteins is absolutely required for 01 panicle assembly and 
budding since expression of the N, NS, L, and either the M 
or G proteins did not suppon panicle budding. The infectivity 
of these particles could be neutralized by anti-VSV and 
anti-G antisera but not by anti-N antiserum. indicating that 
these particles contained G protein on the envelope with the 
nucleocapsid enclosed inside. The panicles were also similar 
in size and morphology to the authentic 01 panicles gener-
ated from cells coinfected with helper VSV. 
Cotransfection with plasmid DNAs containing all fi ve VSV 
genes resulted in synthesis of all five VSV proteins. The 
molar ratios oftheG, N, and M proteins in cells coexpressing 
all five VSV proteins were comparable to those of the cells 
infected with VSV. The NS and L proteins, however, were 
synthesized in amounts that were less than those seen in 
VSV -infected cells. In previous work. we showed that in cells 
cotransfected with plasmids bearing the genes for the N. NS, 
and L proteins, expression of one protein did not interfere 
with the expression of other VSV proteins (8). This. how-
ever, was not found to be the case in cells coexpressing all 
five VSV proteins. Coexpression of M protein with other 
VSV proteins led to inhibition of expression of other VSV 
proteins. This result is intriguing, panicularly in the context 
of the vaccinia virus TI-RNA polymerase expression system, 
since the M protein has been shown to inhibit VSV RNA 
transcription by condensing the nucleocapsids into transcrip-
tionally inactive forms (33-35). In VSV-infected cells, VSV-
specific proteins are synthesized by polyribosomes in asso-
ciation with the cytoskeletal framework (36) and it has been 
postulated that the M protein may disrupt the cytoskeletal 
framework (23). It is possible. therefore, that the M protein 
inhibits the expression of other VSV proteins at the level of 
translation. Further experiments are required to examine the 
mechanism of inhibition of protein expression by the M 
protein. 
We have shown previously that the level of proteins in 
transfected cells can be controlled by the amount of DNA 
plasmid transfected into the cell. Therefore, it shou ld be 
Proc. NaIl. Acad. Sci. USA 88 (/991) 
FIG. 4. Electron microscopic analysis of Dl particles. 01 parti-
cles isolated and partially purified from culture fluids of cells 
coinfected with helper VSV and D1 particles (A) or from cells 
transfected with all fivc: plasmids as described in Fig. ) , lanc: 6, and 
infected with 01 particles (8) are shown. Arrows in 8 show the 
vector·supported budded particles. (Bar '" 200 nm.) 
possible to increase the expression of the NS and L proteins 
by increasing the amount of the corresponding plasmid DNAs 
in transfection such that the molar ratios of all five VSV 
proteins are comparable to those seen in VSV-infected cells. 
Nevertheless, the levels of proteins synthesized in cells 
transfected with all five plasmids under the conditions used 
here supported replication , assembly, and budding of DI 
particles. DI particle budding from cells expressing all five 
VSV proteins was readily detectable using the RNA repli-
cation assay and the number of budded particles represented 
5-10% of those obtained from helper VSV-coinfected cells. 
Using HEp-2 cells, we have shown previously that the 
amount ofDl particle RNA replication in cells expressing the 
N, NS, and L protei ns is 8-10 times more than that in cells 
infected with VSV (8) . However, in BHK-21 cells (used here 
because they are stable to long-term vaccinia virus infection) 
the amount of DI particle RN A replication in cells expressing 
the three VSV proteins is less than that in cells infected with 
VSV (unpublished observation). The reduced level of vector-
supponed budding of DI particles may be a result of the 
reduced level of RNA replication in BHK-21 cells or due to 
synthesis of suboptimal levels of the fi ve VSV proteins or 
both. The fraction of the cells that express all five VSV 
proteins has not been determined yet but this would influence 
the number of cells that would support Dl particle budding. 
We determined previously that - 40% of the cells in culture 
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coexpressed the N, NS, and L proteins when cotransfected 
with the corresponding plasmid DNAs (8). 
Using the vaccinia virus-T7 RNA polymerase expression 
system, Li et al. (19, 20) were able to express the M protein 
that could complement a temperature-sensitive mutant 
(ts023) with a defect in the M gene, However, Blondel et al. 
(23) were unable to detect stable expression of the M protein 
by using a simian virus 40 expression system. The inability to 
detect the M protein expression was correlated with rounding 
and rapid loss of cells expressing the M protein. When the M 
protein was expressed alone or with other VSV proteins, we 
did not observe any cell rounding or detachment even at 20 
hr after transfect ion in the experiments described here. It is 
hypothesized that the abil ity of M protein to cause cell 
rounding and subsequent detachment of cells is antagonized 
in vaccinia virus·infected cells. 
The ability to generate infectious DI particles from cells 
expressing all five VSV proteins provides a way to apply 
reverse genetics to VSV . In particular, detai led structure-
function analysis of VSV proteins and their interactions with 
each other during RNA replication, assembly, and budding of 
virus particles can now be undertaken. The replication sys-
tem has been used already to analyze the funct ional defects 
in temperature-sensitive mutants of VSV with lesions in the 
N gene (ref. 37; 1. Glass and G.W.W., Unpublished obser-
vations). Additionally, dominant negative deletion mutants 
ofNS protein that interfere with the normal fUnctioning of the 
wi ld-type NS protein have been identified (ref. 38; M. How-
ard, A.K.P., and G.W.W., unpublished observations). Stud-
ies on the assembly and budding of OJ particles containing 
heterologous glycoproteins or chimeras between VSV G 
protein and other viral g1ycoproteins should provide infor-
mation on the mechanisms of generation of viral pseudo· 
types. Furthermore, in VSV-infected cells positive- and 
negative-strand RNAs are encapsidated but only the nucleo-
caps ids containing the negative-strand RNA are incorporated 
into budded virions. The mechanism by which this selection 
is exerted is not known at present but can be addressed by 
experiments using the system we have described above. Most 
importantly, the system we have described above provides 
the ability to make specific changes in each of the individual 
proteins of VSV and to study the role of the viral proteins in 
each step of the replicative cycle of VSV-that is, replica-
tion, assembly, and budding. In addition. it is anticipated that 
this system should be applicable to other negat ive-strand 
virus systems for which complete cDNA copies of the viral 
genes are available. 
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